Editorial illustration for Microsoft, OpenAI end pact; OpenAI can now sell on AWS and Google Cloud
Microsoft, OpenAI end pact; OpenAI can now sell on AWS...
AI could also help discover new drugs for resistant infections and predict the spread of resistant bacteria. The UK’s National Health Service is working with Google DeepMind to develop an AI system to combat antibiotic resistance. In one demonstration, the system identified previously unknown mechanisms of resistance in just 48 hours, cracking a mystery that had taken researchers at Imperial College London a decade to understand.
OpenAI’s sudden freedom from Azure changes everything for global health. High-accuracy diagnostic models can now be deployed on AWS or Google Cloud. This is critical where labs are scarce.
Take the WHO's 2023 finding: one in three infections was already resistant in southeast Asia. In Africa, one in five. Darzi’s cited 99% accuracy, achievable without a single new microscope, becomes a tangible lifeline for a remote clinic.
This is happening now. The UK's NHS is already building such a system with Google DeepMind.
Common Questions Answered
What changed in the Microsoft and OpenAI partnership regarding cloud services?
Microsoft and OpenAI ended their exclusive cloud contract, which previously restricted OpenAI to using Microsoft Azure. OpenAI can now sell its AI models directly on Amazon Web Services and Google Cloud, giving the company significantly more flexibility in choosing cloud infrastructure providers.
How does OpenAI's freedom to use AWS and Google Cloud impact healthcare diagnostics?
With access to multiple cloud platforms, high-accuracy diagnostic AI models can now be deployed more widely across different healthcare systems and regions. This is particularly critical for remote clinics in areas with limited lab resources, where diagnostic models achieving 99% accuracy can serve as a lifeline without requiring additional microscopes or equipment.
Why is OpenAI's multi-cloud capability important for addressing antibiotic resistance in developing regions?
OpenAI's ability to deploy on AWS and Google Cloud enables rapid distribution of diagnostic models to regions facing severe antibiotic resistance challenges, such as Southeast Asia where one in three infections showed resistance and Africa where one in five infections were resistant according to WHO's 2023 findings. These AI-powered diagnostic systems can be deployed on existing cloud infrastructure in underserved areas, helping identify resistant infections without waiting for new microscopy equipment.
Is the NHS already implementing diagnostic systems using OpenAI's models on alternative cloud platforms?
Yes, the UK's NHS is already building diagnostic systems that leverage high-accuracy AI models, which can now potentially utilize the expanded cloud options available through OpenAI's new multi-cloud strategy. This demonstrates that the practical implementation of these diagnostic tools is happening now, not as a future possibility.
Further Reading
- OpenAI ends Microsoft legal peril over its $50B Amazon deal — TechCrunch
- Microsoft and OpenAI Loosen Their Landmark AI Alliance, Opening Door to AWS and Other Cloud Platforms — Windows Forum
- Microsoft and OpenAI end exclusivity agreement, opening up potential partnerships with Amazon and Google — Tom's Hardware
- OpenAI breaks free of Microsoft's cloud — Axios